C Bouffioux

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 2.9K citations

Individual Patients, Urology, Urologic Cancer Epidemiology +7

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

Maurizio Brausi, Laurence Collette, Karl‐Heinz Kurth et al. · European Urology · 2002 · 677 citations

Urology, First Follow-up Cystoscopy, Recurrence Rate +8

A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.

Adam Pawinski, Richard Sylvester, K. H. Kurth et al. · PubMed · 1996 · 264 citations

A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer

Adam Pawinski, Richard Sylvester, K. H. Kurth et al. · The Journal of Urology · 1996 · 244 citations

Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter Trial

Jean de Leval, Philippe Boca, Enis Youssef et al. · Clinical Prostate Cancer · 2002 · 136 citations

Urology, Medicine, Benign Prostatic Hyperplasia +4